Arcadia Biosciences completes a $4 million private placement, according to reports from multiple outlets. Following the announcement, the company’s shares fall, with Seeking Alpha noting an intraday dip of about 8%. Investing.com also reports the closing of the placement, indicating the funding has been finalized rather than merely proposed. The coverage centers on the transaction amount and its immediate market impact. No detailed terms of the offering are included in the provided excerpts, such as the pricing, number of shares issued, or whether the placement involves specific investors or convertible securities. However, both sources agree that the company’s private placement is valued at $4 million and that it occurs in the context of a short-term decline in the stock price. Overall, the news describes the completion of the financing and the market reaction in the period immediately surrounding the close of the offering, without additional operational or strategic changes.